miR-23a-3p was reported as a key regulator of IL-17C-induced tumor angiogenesis in CRC (70), and high expression of miRNA-126 is related to increased VEGF-A signaling in endothelial cells and might be a promising biomarker for anti-angiogenic therapies (71). The gene discussed is VEGFA; the disease is neoplasm.